 | • レポートコード：MRC308GR11434 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のイトプリド塩酸塩錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のイトプリド塩酸塩錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– イトプリド塩酸塩錠の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
イトプリド塩酸塩錠市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・12個/箱、20個/箱、その他
用途別セグメント
・心窩部不快感、食後膨満感、食欲不振、その他
主要な市場プレーヤー
・Abbott Laboratories、Nichi-iko Pharmaceutical Co.,Ltd、Tsubame Labo, Inc、Livzon Pharmaceutical Group Inc、Jiangsu Hengrui Pharmaceuticals Co., Ltd、Zhuhai Rundu Pharmaceutical Co.,Ltd、HARBIN PHARMACEUTICAL GROUP CO.,LTD、Liaoning Gaoxin Pharmaceutical Co., Ltd、Suzhou Amyjin Pharmaceutical Co., Ltd、Yunnan Yong’an Pharmaceutical Co., Ltd、Disha Pharmaceutical Group Co., Ltd
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、イトプリド塩酸塩錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なイトプリド塩酸塩錠メーカーの企業概要、2019年～2022年までのイトプリド塩酸塩錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なイトプリド塩酸塩錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別イトプリド塩酸塩錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのイトプリド塩酸塩錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのイトプリド塩酸塩錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびイトプリド塩酸塩錠の産業チェーンを掲載しています。
・第14、15章では、イトプリド塩酸塩錠の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– イトプリド塩酸塩錠の概要
– 種類別分析（2018年vs2022年vs2029年）：12個/箱、20個/箱、その他
– 用途別分析（2018年vs2022年vs2029年）：心窩部不快感、食後膨満感、食欲不振、その他
– 世界のイトプリド塩酸塩錠市場規模・予測
– 世界のイトプリド塩酸塩錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Abbott Laboratories、Nichi-iko Pharmaceutical Co.,Ltd、Tsubame Labo, Inc、Livzon Pharmaceutical Group Inc、Jiangsu Hengrui Pharmaceuticals Co., Ltd、Zhuhai Rundu Pharmaceutical Co.,Ltd、HARBIN PHARMACEUTICAL GROUP CO.,LTD、Liaoning Gaoxin Pharmaceutical Co., Ltd、Suzhou Amyjin Pharmaceutical Co., Ltd、Yunnan Yong’an Pharmaceutical Co., Ltd、Disha Pharmaceutical Group Co., Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：12個/箱、20個/箱、その他
・用途別分析2018年-2029年：心窩部不快感、食後膨満感、食欲不振、その他
・イトプリド塩酸塩錠の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・イトプリド塩酸塩錠のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・イトプリド塩酸塩錠のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・イトプリド塩酸塩錠の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・イトプリド塩酸塩錠の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Itopride Hydrochloride Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Itopride Hydrochloride Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 12pieces/box
1.3.3 20 pieces/box
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Itopride Hydrochloride Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Epigastric Discomfort
1.4.3 Postprandial Fullness
1.4.4 Loss Of Appetite
1.4.5 Others
1.5 Global Itopride Hydrochloride Tablets Market Size & Forecast
1.5.1 Global Itopride Hydrochloride Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Itopride Hydrochloride Tablets Sales Quantity (2018-2029)
1.5.3 Global Itopride Hydrochloride Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Itopride Hydrochloride Tablets Product and Services
2.1.4 Abbott Laboratories Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments/Updates
2.2 Nichi-iko Pharmaceutical Co.,Ltd
2.2.1 Nichi-iko Pharmaceutical Co.,Ltd Details
2.2.2 Nichi-iko Pharmaceutical Co.,Ltd Major Business
2.2.3 Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product and Services
2.2.4 Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Nichi-iko Pharmaceutical Co.,Ltd Recent Developments/Updates
2.3 Tsubame Labo, Inc
2.3.1 Tsubame Labo, Inc Details
2.3.2 Tsubame Labo, Inc Major Business
2.3.3 Tsubame Labo, Inc Itopride Hydrochloride Tablets Product and Services
2.3.4 Tsubame Labo, Inc Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Tsubame Labo, Inc Recent Developments/Updates
2.4 Livzon Pharmaceutical Group Inc
2.4.1 Livzon Pharmaceutical Group Inc Details
2.4.2 Livzon Pharmaceutical Group Inc Major Business
2.4.3 Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Product and Services
2.4.4 Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Livzon Pharmaceutical Group Inc Recent Developments/Updates
2.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd
2.5.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
2.5.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
2.5.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Product and Services
2.5.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
2.6 Zhuhai Rundu Pharmaceutical Co.,Ltd
2.6.1 Zhuhai Rundu Pharmaceutical Co.,Ltd Details
2.6.2 Zhuhai Rundu Pharmaceutical Co.,Ltd Major Business
2.6.3 Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product and Services
2.6.4 Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zhuhai Rundu Pharmaceutical Co.,Ltd Recent Developments/Updates
2.7 HARBIN PHARMACEUTICAL GROUP CO.,LTD
2.7.1 HARBIN PHARMACEUTICAL GROUP CO.,LTD Details
2.7.2 HARBIN PHARMACEUTICAL GROUP CO.,LTD Major Business
2.7.3 HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Product and Services
2.7.4 HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 HARBIN PHARMACEUTICAL GROUP CO.,LTD Recent Developments/Updates
2.8 Liaoning Gaoxin Pharmaceutical Co., Ltd
2.8.1 Liaoning Gaoxin Pharmaceutical Co., Ltd Details
2.8.2 Liaoning Gaoxin Pharmaceutical Co., Ltd Major Business
2.8.3 Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product and Services
2.8.4 Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Liaoning Gaoxin Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Suzhou Amyjin Pharmaceutical Co., Ltd
2.9.1 Suzhou Amyjin Pharmaceutical Co., Ltd Details
2.9.2 Suzhou Amyjin Pharmaceutical Co., Ltd Major Business
2.9.3 Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product and Services
2.9.4 Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Suzhou Amyjin Pharmaceutical Co., Ltd Recent Developments/Updates
2.10 Yunnan Yong’an Pharmaceutical Co., Ltd
2.10.1 Yunnan Yong’an Pharmaceutical Co., Ltd Details
2.10.2 Yunnan Yong’an Pharmaceutical Co., Ltd Major Business
2.10.3 Yunnan Yong’an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product and Services
2.10.4 Yunnan Yong’an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Yunnan Yong’an Pharmaceutical Co., Ltd Recent Developments/Updates
2.11 Disha Pharmaceutical Group Co., Ltd
2.11.1 Disha Pharmaceutical Group Co., Ltd Details
2.11.2 Disha Pharmaceutical Group Co., Ltd Major Business
2.11.3 Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Product and Services
2.11.4 Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Disha Pharmaceutical Group Co., Ltd Recent Developments/Updates
3 Competitive Environment: Itopride Hydrochloride Tablets by Manufacturer
3.1 Global Itopride Hydrochloride Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Itopride Hydrochloride Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Itopride Hydrochloride Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Itopride Hydrochloride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Itopride Hydrochloride Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Itopride Hydrochloride Tablets Manufacturer Market Share in 2022
3.5 Itopride Hydrochloride Tablets Market: Overall Company Footprint Analysis
3.5.1 Itopride Hydrochloride Tablets Market: Region Footprint
3.5.2 Itopride Hydrochloride Tablets Market: Company Product Type Footprint
3.5.3 Itopride Hydrochloride Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Itopride Hydrochloride Tablets Market Size by Region
4.1.1 Global Itopride Hydrochloride Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Itopride Hydrochloride Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Itopride Hydrochloride Tablets Average Price by Region (2018-2029)
4.2 North America Itopride Hydrochloride Tablets Consumption Value (2018-2029)
4.3 Europe Itopride Hydrochloride Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Itopride Hydrochloride Tablets Consumption Value (2018-2029)
4.5 South America Itopride Hydrochloride Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Itopride Hydrochloride Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2029)
5.2 Global Itopride Hydrochloride Tablets Consumption Value by Type (2018-2029)
5.3 Global Itopride Hydrochloride Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2029)
6.2 Global Itopride Hydrochloride Tablets Consumption Value by Application (2018-2029)
6.3 Global Itopride Hydrochloride Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2029)
7.2 North America Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2029)
7.3 North America Itopride Hydrochloride Tablets Market Size by Country
7.3.1 North America Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Itopride Hydrochloride Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Itopride Hydrochloride Tablets Market Size by Country
8.3.1 Europe Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Itopride Hydrochloride Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Itopride Hydrochloride Tablets Market Size by Region
9.3.1 Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Itopride Hydrochloride Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2029)
10.2 South America Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2029)
10.3 South America Itopride Hydrochloride Tablets Market Size by Country
10.3.1 South America Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Itopride Hydrochloride Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Itopride Hydrochloride Tablets Market Size by Country
11.3.1 Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Itopride Hydrochloride Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Itopride Hydrochloride Tablets Market Drivers
12.2 Itopride Hydrochloride Tablets Market Restraints
12.3 Itopride Hydrochloride Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Itopride Hydrochloride Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Itopride Hydrochloride Tablets
13.3 Itopride Hydrochloride Tablets Production Process
13.4 Itopride Hydrochloride Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Itopride Hydrochloride Tablets Typical Distributors
14.3 Itopride Hydrochloride Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Itopride Hydrochloride Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Itopride Hydrochloride Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Itopride Hydrochloride Tablets Product and Services
Table 6. Abbott Laboratories Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Laboratories Recent Developments/Updates
Table 8. Nichi-iko Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Nichi-iko Pharmaceutical Co.,Ltd Major Business
Table 10. Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product and Services
Table 11. Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Nichi-iko Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 13. Tsubame Labo, Inc Basic Information, Manufacturing Base and Competitors
Table 14. Tsubame Labo, Inc Major Business
Table 15. Tsubame Labo, Inc Itopride Hydrochloride Tablets Product and Services
Table 16. Tsubame Labo, Inc Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Tsubame Labo, Inc Recent Developments/Updates
Table 18. Livzon Pharmaceutical Group Inc Basic Information, Manufacturing Base and Competitors
Table 19. Livzon Pharmaceutical Group Inc Major Business
Table 20. Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Product and Services
Table 21. Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Livzon Pharmaceutical Group Inc Recent Developments/Updates
Table 23. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 25. Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Product and Services
Table 26. Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 28. Zhuhai Rundu Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Zhuhai Rundu Pharmaceutical Co.,Ltd Major Business
Table 30. Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product and Services
Table 31. Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zhuhai Rundu Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 33. HARBIN PHARMACEUTICAL GROUP CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 34. HARBIN PHARMACEUTICAL GROUP CO.,LTD Major Business
Table 35. HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Product and Services
Table 36. HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. HARBIN PHARMACEUTICAL GROUP CO.,LTD Recent Developments/Updates
Table 38. Liaoning Gaoxin Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Liaoning Gaoxin Pharmaceutical Co., Ltd Major Business
Table 40. Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product and Services
Table 41. Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Liaoning Gaoxin Pharmaceutical Co., Ltd Recent Developments/Updates
Table 43. Suzhou Amyjin Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Suzhou Amyjin Pharmaceutical Co., Ltd Major Business
Table 45. Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product and Services
Table 46. Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Suzhou Amyjin Pharmaceutical Co., Ltd Recent Developments/Updates
Table 48. Yunnan Yong'an Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Yunnan Yong'an Pharmaceutical Co., Ltd Major Business
Table 50. Yunnan Yong'an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product and Services
Table 51. Yunnan Yong'an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Yunnan Yong'an Pharmaceutical Co., Ltd Recent Developments/Updates
Table 53. Disha Pharmaceutical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Disha Pharmaceutical Group Co., Ltd Major Business
Table 55. Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Product and Services
Table 56. Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Disha Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 58. Global Itopride Hydrochloride Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Itopride Hydrochloride Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Itopride Hydrochloride Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Itopride Hydrochloride Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Itopride Hydrochloride Tablets Production Site of Key Manufacturer
Table 63. Itopride Hydrochloride Tablets Market: Company Product Type Footprint
Table 64. Itopride Hydrochloride Tablets Market: Company Product Application Footprint
Table 65. Itopride Hydrochloride Tablets New Market Entrants and Barriers to Market Entry
Table 66. Itopride Hydrochloride Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Itopride Hydrochloride Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Itopride Hydrochloride Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Itopride Hydrochloride Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Itopride Hydrochloride Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Itopride Hydrochloride Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Itopride Hydrochloride Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Itopride Hydrochloride Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Itopride Hydrochloride Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Itopride Hydrochloride Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Itopride Hydrochloride Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Itopride Hydrochloride Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Itopride Hydrochloride Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Itopride Hydrochloride Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Itopride Hydrochloride Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Itopride Hydrochloride Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Itopride Hydrochloride Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Itopride Hydrochloride Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Itopride Hydrochloride Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Itopride Hydrochloride Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Itopride Hydrochloride Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Itopride Hydrochloride Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Itopride Hydrochloride Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Itopride Hydrochloride Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Itopride Hydrochloride Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Itopride Hydrochloride Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Itopride Hydrochloride Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Itopride Hydrochloride Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Itopride Hydrochloride Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Itopride Hydrochloride Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Itopride Hydrochloride Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Itopride Hydrochloride Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Itopride Hydrochloride Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Itopride Hydrochloride Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Itopride Hydrochloride Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Itopride Hydrochloride Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Itopride Hydrochloride Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Itopride Hydrochloride Tablets Raw Material
Table 126. Key Manufacturers of Itopride Hydrochloride Tablets Raw Materials
Table 127. Itopride Hydrochloride Tablets Typical Distributors
Table 128. Itopride Hydrochloride Tablets Typical Customers
List of Figures
Figure 1. Itopride Hydrochloride Tablets Picture
Figure 2. Global Itopride Hydrochloride Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Itopride Hydrochloride Tablets Consumption Value Market Share by Type in 2022
Figure 4. 12pieces/box Examples
Figure 5. 20 pieces/box Examples
Figure 6. Others Examples
Figure 7. Global Itopride Hydrochloride Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Itopride Hydrochloride Tablets Consumption Value Market Share by Application in 2022
Figure 9. Epigastric Discomfort Examples
Figure 10. Postprandial Fullness Examples
Figure 11. Loss Of Appetite Examples
Figure 12. Others Examples
Figure 13. Global Itopride Hydrochloride Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Itopride Hydrochloride Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Itopride Hydrochloride Tablets Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Itopride Hydrochloride Tablets Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Itopride Hydrochloride Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Itopride Hydrochloride Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Itopride Hydrochloride Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Itopride Hydrochloride Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Itopride Hydrochloride Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Itopride Hydrochloride Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Itopride Hydrochloride Tablets Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Itopride Hydrochloride Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Itopride Hydrochloride Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Itopride Hydrochloride Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Itopride Hydrochloride Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Itopride Hydrochloride Tablets Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Itopride Hydrochloride Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Itopride Hydrochloride Tablets Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Itopride Hydrochloride Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Itopride Hydrochloride Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Itopride Hydrochloride Tablets Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Itopride Hydrochloride Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Itopride Hydrochloride Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Itopride Hydrochloride Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Itopride Hydrochloride Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Itopride Hydrochloride Tablets Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Itopride Hydrochloride Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Itopride Hydrochloride Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Itopride Hydrochloride Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Itopride Hydrochloride Tablets Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Itopride Hydrochloride Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Itopride Hydrochloride Tablets Consumption Value Market Share by Region (2018-2029)
Figure 55. China Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Itopride Hydrochloride Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Itopride Hydrochloride Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Itopride Hydrochloride Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Itopride Hydrochloride Tablets Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Itopride Hydrochloride Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Itopride Hydrochloride Tablets Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Itopride Hydrochloride Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Itopride Hydrochloride Tablets Market Drivers
Figure 76. Itopride Hydrochloride Tablets Market Restraints
Figure 77. Itopride Hydrochloride Tablets Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Itopride Hydrochloride Tablets in 2022
Figure 80. Manufacturing Process Analysis of Itopride Hydrochloride Tablets
Figure 81. Itopride Hydrochloride Tablets Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source